B1a B Lymphocytes Are Atheroprotective by Secreting Natural IgM That Increases IgM Deposits and Reduces Necrotic Cores in Atherosclerotic Lesions

Rationale: Aggravated atherosclerosis in B lymphocyte-deficient chimeric mice and reduced atherosclerosis after transfer of unfractionated spleen B lymphocytes into splenectomized mice have led to the widely held notion that B lymphocytes are atheroprotective. However, B lymphocytes can be pathogenic, because their depletion by anti-CD20 antibody ameliorated atherosclerosis, and transfer of B2 lymphocytes aggravated atherosclerosis. These observations raise the question of the identity of the atheroprotective B-lymphocyte population. Objective: The purpose of the study was to identify an atheroprotective B-lymphocyte subset and mechanisms by which they confer atheroprotection. Methods and Results: Splenectomy of apolipoprotein E–deficient mice selectively reduced peritoneal B1a lymphocytes, plasma IgM, and oxidized low-density lipoprotein IgM levels and lesion IgM deposits. These reductions were accompanied by increased oil red O–stained atherosclerotic lesions and increased necrotic cores, oxidized low-density lipoproteins, and apoptotic cells in lesions. Plasma lipids, body weight, collagen, and smooth muscle content were unaffected. Transfer of B1a lymphocytes into splenectomized mice increased peritoneal B1a lymphocytes; restored plasma IgM, oxidized low-density lipoprotein IgM levels, and lesion IgM deposits; and potently attenuated atherosclerotic lesions, with reduced lesion necrotic cores, oxidized low-density lipoprotein, and apoptotic cells. In contrast, transfer of B1a lymphocytes that cannot secrete IgM failed to protect against atherosclerosis development in splenectomized mice despite reconstitution in the peritoneum. Conclusions: B1a lymphocytes are an atheroprotective B-lymphocyte population. Our data suggest that natural IgM secreted by these lymphocytes offers protection by depositing IgM in atherosclerotic lesions, which reduces the necrotic cores of lesions.

[1]  M. Ehrenstein,et al.  The importance of natural IgM: scavenger, protector and regulator , 2010, Nature Reviews Immunology.

[2]  P. Tipping,et al.  Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis , 2010, The Journal of Immunology.

[3]  J. Monroe,et al.  B‐cell targeted therapies in human autoimmune diseases: an updated perspective , 2010, Immunological reviews.

[4]  C. Uyttenhove,et al.  B cell depletion reduces the development of atherosclerosis in mice , 2010, The Journal of experimental medicine.

[5]  J. Boyle,et al.  Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice , 2009, Circulation.

[6]  G. Hansson,et al.  Vaccination against atherosclerosis? Induction of atheroprotective immunity , 2009, Seminars in Immunopathology.

[7]  F. Bäckhed,et al.  Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. , 2009, The Journal of clinical investigation.

[8]  K. Ley,et al.  Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.

[9]  N. Baumgarth,et al.  Dual role for B-1a cells in immunity to influenza virus infection , 2008, The Journal of experimental medicine.

[10]  D. Schrijvers,et al.  Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe−/− Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Ş. Şimsek,et al.  The Effects of Splenectomy and Splenic Autotransplantation on Plasma Lipid Levels , 2008, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[12]  J. Witztum,et al.  Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.R500005-JLR200 , 2005, Journal of Lipid Research.

[13]  J. Witztum,et al.  The role of natural antibodies in atherogenesis. , 2005, Journal of lipid research.

[14]  L. Herzenberg,et al.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.

[15]  Kenneth G. Johnson,et al.  CD22 Is a Functional Ligand for SH2 Domain-containing Protein-tyrosine Phosphatase-1 in Primary T Cells* , 2004, Journal of Biological Chemistry.

[16]  J. Witztum,et al.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.

[17]  M. Linton,et al.  B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[18]  H. Wardemann,et al.  B-1a B Cells that Link the Innate and Adaptive Immune Responses Are Lacking in the Absence of the Spleen , 2002, The Journal of experimental medicine.

[19]  G. Hansson,et al.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. , 2002, The Journal of clinical investigation.

[20]  Pojen P. Chen,et al.  Human-Derived Anti-Oxidized LDL Autoantibody Blocks Uptake of Oxidized LDL by Macrophages and Localizes to Atherosclerotic Lesions In Vivo , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[21]  J. Kearney,et al.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.

[22]  J. Kearney,et al.  B1 cells: similarities and differences with other B cell subsets. , 2001, Current opinion in immunology.

[23]  A. Becker,et al.  Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses , 2001, The Journal of pathology.

[24]  Jianzhu Chen,et al.  B-1 and B-2 Cell–Derived Immunoglobulin M Antibodies Are Nonredundant Components of the Protective Response to Influenza Virus Infection , 2000, The Journal of experimental medicine.

[25]  G. Silverman,et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.

[26]  Hansson,et al.  Detection of B Cells and Proinflammatory Cytokines in Atherosclerotic Plaques of Hypercholesterolaemic Apolipoprotein E Knockout Mice , 1999, Scandinavian journal of immunology.

[27]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[28]  Jianzhu Chen,et al.  Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.

[29]  G. Hansson,et al.  Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. , 1998, The Journal of clinical investigation.

[30]  A. Coutinho,et al.  The repertoire of serum IgM in normal mice is largely independent of external antigenic contact , 1997, European journal of immunology.

[31]  A. Coutinho,et al.  Natural autoantibodies. , 1995, Current opinion in immunology.

[32]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[33]  M. Kuzuya,et al.  Effects of Splenectomy on Serum Lipids and Experimental Atherosclerosis , 1988, Angiology.

[34]  Klaus Rajewsky,et al.  The half‐lives of serum immunoglobulins in adult mice , 1988, European journal of immunology.

[35]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[36]  R. Hardy,et al.  Progenitors for Ly-1 B cells are distinct from progenitors for other B cells , 1985, The Journal of experimental medicine.

[37]  J. Fraumeni,et al.  SPLENECTOMY AND SUBSEQUENT MORTALITY IN VETERANS OF THE 1939-45 WAR , 1977, The Lancet.

[38]  S. Shapiro THE INFLUENCE OF THYROIDECTOMY, SPLENECTOMY, GONADECTOMY, AND SUPRARENALECTOMY UPON THE DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS , 1927, The Journal of experimental medicine.